Both Ozempic and Wegovy contain the active ingredient semaglutide and belong to the group of so-called GLP-1 receptor agonists
News The latest chemistry news, including important research advances, business and policy trends, chemical safety practices, career guidance, and more
Was your condition diagnosed by a specialist, such as a gastroenterologist or ophthalmologist
The hearing will take place on Dec
with FDA-approved products containing semaglutide, identified under the trade names Wegovy, Ozempic, and RYBELSUS, and should only be prescribed after a close consultation between a healthcare provider and a patient and should only be taken under the supervision of a healthcare provider," the company said in a statement